Blood biomarker changes following therapeutic hypothermia in ischemic stroke
Therapeutic hypothermia is a promising candidate for stroke treatment although its efficacy has not yet been demonstrated in patients. Changes in blood molecules could act as surrogate markers to evaluate the efficacy and safety of therapeutic cooling.
| Autores: | , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/348049 |
| Acesso em linha: | http://hdl.handle.net/10261/348049 https://api.elsevier.com/content/abstract/scopus_id/85171444564 |
| Access Level: | acceso abierto |
| Palavra-chave: | Biomarkers Hypothermia Ischemia Stroke |
| Resumo: | Therapeutic hypothermia is a promising candidate for stroke treatment although its efficacy has not yet been demonstrated in patients. Changes in blood molecules could act as surrogate markers to evaluate the efficacy and safety of therapeutic cooling. |
|---|